Association between commercial funding of Canadian patient groups and their views about funding of medicines: An observational study.

ABSTRACT:

Background

Patient groups represent the interest of their members when it comes to drug funding. Many patient groups receive grants from pharmaceutical companies that make products being considered for funding. This research examines whether there is an association between the positions that Canadian groups take about the products and conflicts of interest with the companies.

Methods

The Common Drug Review (CDR) and panCanadian Oncology Drug Review (pCODR) make recommendations to Canadian provincial and federal drug plans about funding particular drug-indications. Both utilize input from patient groups in making their recommendations. Patient group submissions are available from both organizations and these submissions contain statements about conflicts of interest. Views of

SUBMITTER: Lexchin J 

PROVIDER: S-EPMC6377138 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature